ABIONYX Pharma SA (EPA: ABNX)
France
· Delayed Price · Currency is EUR 1.236
+0.016 (1.32%)
Dec 20, 2024, 2:30 PM CET
ABIONYX Pharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -3.36 | -3.52 | -4.21 | -5.82 | -1.89 | 1.85 | Upgrade
|
| Depreciation & Amortization | 0.14 | 0.14 | 0.12 | 0.12 | 0.02 | 0.01 | Upgrade
|
| Other Amortization | 0.01 | 0.01 | 0.01 | 0 | - | - | Upgrade
|
| Stock-Based Compensation | 0.37 | 0.02 | 0.51 | 0.82 | 0.1 | 0.1 | Upgrade
|
| Other Operating Activities | -0.87 | -0.89 | 0.11 | -0.06 | -0.96 | -4.61 | Upgrade
|
| Change in Accounts Receivable | 0.38 | 0.38 | 0.04 | -0.1 | - | - | Upgrade
|
| Change in Inventory | -0.08 | -0.08 | 0.03 | 0.01 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 0.37 | 0.23 | 0.03 | -1.66 | 2.13 | -1.3 | Upgrade
|
| Operating Cash Flow | -3.03 | -3.7 | -3.36 | -6.69 | -0.6 | -3.95 | Upgrade
|
| Capital Expenditures | -0.06 | -0.1 | -0.17 | -0.17 | -0.1 | - | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0 | 0.02 | - | Upgrade
|
| Divestitures | - | - | - | 1.5 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.03 | -0.03 | -0.01 | - | -0.05 | - | Upgrade
|
| Investing Cash Flow | -0.09 | -0.13 | -0.18 | 1.34 | -0.13 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 0.25 | Upgrade
|
| Long-Term Debt Repaid | - | -0.3 | -0.24 | -0.02 | -0.2 | -0.4 | Upgrade
|
| Net Debt Issued (Repaid) | -1.03 | -0.3 | -0.24 | -0.02 | -0.2 | -0.15 | Upgrade
|
| Issuance of Common Stock | 7.53 | 4.19 | 0.04 | 4.06 | 1.84 | 0.97 | Upgrade
|
| Repurchase of Common Stock | -0.01 | - | - | - | - | - | Upgrade
|
| Other Financing Activities | - | - | - | -0.07 | -0.09 | - | Upgrade
|
| Financing Cash Flow | 6.5 | 3.89 | -0.19 | 3.97 | 1.55 | 0.82 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 0 | Upgrade
|
| Net Cash Flow | 3.38 | 0.06 | -3.73 | -1.38 | 0.82 | -3.13 | Upgrade
|
| Free Cash Flow | -3.09 | -3.8 | -3.52 | -6.86 | -0.7 | -3.95 | Upgrade
|
| Free Cash Flow Margin | -63.67% | -81.94% | -67.10% | -1016.00% | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.10 | -0.13 | -0.13 | -0.28 | -0.03 | -0.19 | Upgrade
|
| Levered Free Cash Flow | -1.95 | -2.47 | -2.06 | -5.04 | 0.3 | -3.35 | Upgrade
|
| Unlevered Free Cash Flow | -1.94 | -2.46 | -2.02 | -5.03 | 0.3 | -3.14 | Upgrade
|
| Change in Net Working Capital | 0.3 | 0.37 | -0.08 | 2.08 | -2.18 | 1.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.